Tuhura Biosciences Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Tuhura Biosciences Inc 's ROA in the second quarter of 2026?
Tuhura Biosciences Inc recorded a cumulative net loss of $-31 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -106.98%.

However, within the Healthcare sector 777 other companies had a higher return on assets. While the total ranking for ROA unchanged, relative to the first quarter of 2026 at no. .

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	-8.3 %	102.92 %	36.99 %	520.7 %	-49.73 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-31	-31	-30	-23	-22
Return On Assets (TTM)	-106.98 %	-105.38 %	-117.5 %	-98.17 %	-118.7 %
HURA's Total Ranking	#	#	#	#	# 4908
Total Assets (TTM) in million	32	30	27	26	35
Seq. Total Assets Change	6.87 %	8.6 %	6.44 %	-25.78 %	136.51 %
Seq. Net Income Change	-	-	-	-	-

HURA's 5 Years Annual ROA >> Back to HURA Management Effectiveness >> Compare HURA ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 365
Sector	# 778
Overall	# 4359

Return On Assets Statistics
High	Average	Low
349.64 %	-40.87 %	-616.79 %
(Mar 31 2020)		(Mar 31 2022)

Financial Statements
Tuhura Biosciences Inc 's Assets	$ 32 million	HURA's Balance sheet
Tuhura Biosciences Inc 's Income	$ -9 million	Quarterly HURA's Income Statement
HURA's Income by Division		See HURA's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Jun 30 2023) FY 2023	(Jun 30 2022) FY 2022	(Jun 30 2021) FY 2021
Y / Y Total Assets Change	-1.65 %	401.8 %	-74.07 %	13.33 %	360.94 %
Total Assets in million	20	20	4	15	14
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-30	-23	-15	-25	-38
Annual Return On Assets	-153.04 %	-113.44 %	-368.36 %	-163.74 %	-282.85 %

HURA's 5 Years Annual ROA >> Back to HURA Management Effectiveness >> Compare HURA ROA to its Competitors

More Return On Assets Ratios
HURA's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
HURA's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for HURA's Competitors
Subscribers only: Roa for Tuhura Biosciences Inc 's Suppliers
Subscribers only: Return On Assets for HURA's Customers

You may also want to know
HURA's Roi	HURA's Inventory Turnover Ratio	HURA's Growth Rates	HURA's Dividend Comparisons
	HURA's Profitability Ratios	HURA's Asset Turnover Ratio	HURA's Dividend Growth
HURA's Roe	HURA's Valuation Ratios	HURA's Financial Strength Ratios	HURA's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-08-18T17:26:33+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.